Question explored with the scientific record
Is the nasal spray bad for kids
The short version: steroid nasal sprays are the low-risk option; decongestant sprays are the one to watch, especially in small kids.
The question is broad, so the answer splits by what is actually in the bottle. For steroid sprays, a review of 33 studies in children under 12 found headache and nosebleeds no more common than with placebo, and serious whole-body steroid effects rare with the approved products [1]. The catch: unapproved steroid drops put into the nose were linked to cases of adrenal suppression and Cushing's, and growth effects were mixed across trials [1]. Use the labeled product, not a repurposed drop.
Decongestant sprays are where the real danger sits. A 4-year-old boy under anesthesia got a blood pressure jump from 100/52 to 170/110 after oxymetazoline [3]. The likely cause was technique: an inverted bottle delivered up to 75 times the upright dose [3]. A healthy man in his early 30s had a heart attack after three days of oxymetazoline [2]. Long-term use also causes rebound stuffiness and nasal hyperreactivity [4][5].
| Spray type | Main risk in kids | Evidence |
|---|---|---|
| Steroid (approved) | Headache, nosebleeds near placebo rates | [1] |
| Steroid (unapproved drops) | Adrenal suppression, Cushing's cases | [1] |
| Oxymetazoline | Hypertensive crisis, overdose by technique | [3] |
| Oxymetazoline (long use) | Rebound congestion, hyperreactivity | [4][5] |
What this retrieval cannot see: no long-term growth study in children, and no trial of decongestants in young kids at all.
My call: steroid sprays are reasonable for a child with real symptoms; decongestant sprays are not worth the risk in small children, and if used at all, keep the bottle upright and stop within a few days. Confidence: moderate for steroids, moderate for decongestants.
Sources used 5
-
Intranasal Corticosteroid Therapy: Systematic Review and Meta‐analysis of Reported Safety and Adverse Effects in Children
This is a systematic review and meta-analysis evaluating the safety and adverse effects of intranasal corticosteroids in children, comparing FDA-approved formulations to non-FDA-approved uses, finding general safety with rare systemic effects for FDA-approved INCS while non-FDA …
DOI: 10.1177/0194599820931454 -
Acute Coronary Syndrome After Nasal Spray of Oxymetazoline
This case report describes a healthy young man who developed acute coronary syndrome after using oxymetazoline nasal spray, highlighting the potential cardiovascular risks associated with sympathomimetic drugs even in patients without known risk factors.
DOI: 10.1378/chest.14-1873 -
Oxymetazoline and hypertensive crisis in a child: can we prevent it?
Inverting an oxymetazoline nasal spray bottle can deliver up to 75-fold more drug than upright spraying, and this likely caused an intraoperative hypertensive crisis in a 4-year-old boy.
DOI: 10.1111/pan.12192 -
Effect on the Nasal Mucosa of Long‐Term Treatment With Oxymetazoline, Benzalkonium Chloride, and Placebo Nasal Sprays
This study investigates the effects of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays on nasal mucosa in healthy subjects, revealing that oxymetazoline induces nasal hyperreactivity and a sensation of nasal stuffiness, while benzalkonium …
DOI: 10.1097/00005537-199605000-00016 -
Intranasal alpha-adrenergic receptor agonists and corticosteroids as medical treatments for nasal congestion
Intranasal alpha-adrenergic agonists relieve nasal congestion rapidly but risk rhinitis medicamentosa, while intranasal corticosteroids provide gradual, safe long-term anti-inflammatory relief, per this narrative review.
DOI: 10.54254/2753-8818/27/20240740